March 16 (Reuters) - Alar Pharmaceuticals Inc 6785.TWO:
ALAR PHARMACEUTICALS INC - ANNOUNCES POSITIVE RESULTS FOR ALA-1000 IN CANINE OSTEOARTHRITIS STUDY
ALAR PHARMACEUTICALS INC - ALA-1000 SHOWS FAVORABLE SAFETY PROFILE WITH REPEATED USE IN GERIATRIC DOGS